共 50 条
- [3] Designing non-clinical safety evaluation programmes for monoclonal antibodies for therapeutic use: A personal view SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 103 - 114
- [7] Designing non-clinical safety evaluation programmes: The view of the clinician SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 1 - 6
- [8] Points to consider on the non-clinical safety evaluation of anticancer drugs JOURNAL OF TOXICOLOGICAL SCIENCES, 2008, 33 (02): : 123 - 126
- [9] Designing non-clinical safety evaluation programmes: The view of the toxicologist SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 7 - 15